The Novavax vaccine is a protein subunit vaccine. It uses a synthetic coronavirus spike protein to teach the immune system to produce antibodies that can deactivate the coronavirus if a person were to be exposed
More than 15,000 volunteers were recruited for the Novavax trial in the United Kingdom. The vaccine prevented 9 out of 10 infections, which included the original coronavirus variants and the B.1.1.7 variant detected in the United Kingdom in December.
Results from two clinical trials evaluating Novavax’s coronavirus vaccine show the shot is 89.3% effective at preventing COVID-19.
#Covid19 #vaccine #Novavax #trials #Maqow #getanswersnow